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In	Vitro	Kinetic	Study	of	the	Squalestatin	Tetraketide	Synthase	
Dehydratase	Reveals	the	Stereochemical	Course	of	a	Fungal	
Highly	Reducing	Polyketide	Synthase	
Emma	Liddle,a	Alan	Scott,a	Li-Chen	Han,a	David	Ivison,a	Thomas	J.	Simpson,a	Christine	L.	Willisa	
and	Russell	J.	Coxa,b,c	*	
Six	 potential	 diketide	 substrates	 for	 the	 squalestatin	
tetraketide	synthase	(SQTKS)	dehydratase	(DH)	domain	were	
synthesised	 as	 N-acetyl	 cysteamine	 thiolesters	 (SNAC)	 and	
tested	 in	 kinetic	 assays	 as	 substrates	 with	 an	 isolated	 DH	
domain.	3R-3-Hydroxybutyryl	SNAC	3R-16	was	turned	over	by	
the	enzyme,	but	its	enantiomer	was	not.	Of	the	four	2-methyl	
substrates	 only	 2R,3R-2-methyl-3-hydroxybutyryl	 SNAC	
2R,3R-8	 was	 a	 substrate.	 Combined	 with	 stereochemical	
information	 from	 the	 isolated	 SQTKS	 enoyl	 reductase	 (ER)	
domain,	our	results	provide	a	near	complete	stereochemical	
description	of	the	first	cycle	of	beta-modification	reactions	of	
a	 fungal	 highly	 reducing	 polyketide	 synthase	 (HR-PKS).	 The	
results	emphasise	the	close	relationship	between	fungal	HR-
PKS	and	vertebrate	fatty	acid	synthases	(vFAS).	
	 Iterative	fungal	polyketide	synthases	(PKS)	are	responsible	
for	 the	 biosynthesis	 of	 complex	 and	 often	 biologically	 active	
natural	products	such	as	squalestatin	S1	1	a	potent	inhibitor	of	
squalene	synthase,1,2	and	 lovastatin	2,3	an	 inhibitor	of	human	
HMG-CoA	 reductase.	 These	 PKS	 are	 Type	 I	 systems	 in	 which	
several	 individual	 catalytic	 domains	 are	 covalently	 linked	 to	
form	 a	 mega-complex	 of	 ca	 >200	 KDa.4,5	 Understanding	 the	
selectivity	 and	 programming	 of	 these	 systems	 is	 important	
because	 reprogramming	 them	 could	 lead	 to	 the	 systematic	
creation	of	new	bioactive	materials.	In	order	to	achieve	this	an	
understanding	 of	 the	 individual	 catalytic	 domains	 and	 their	
intrinsic	selectivities	is	required.	
	 The	C10	 side-chain	of	1,	 known	as	 squalestatin	 tetraketide	
3,	 is	synthesised	by	a	highly	reducing	(HR)	 iterative	PKS	called	
squalestatin	 tetraketide	 synthase	 (SQTKS).6,7	 It	 consists	 of	 an	
acyl	 carrier	protein	 (ACP)	which	holds	 the	growing	polyketide	
chain,	a	β-ketoacyl	ACP	synthase	(KS)	which	catalyses	a	Claisen	
condensation	 between	 malonyl	 ACP	 and	 acyl-KS	 and	 an	 acyl	
transferase	 (AT)	 which	 loads	 acetyl	 starter	 and	 malonyl	
extender	 units	 from	 CoA	 onto	 the	 PKS.	 In	 addition,	 SQTKS	
contains:	 β-ketoacyl	 ACP	 ketoreductase	 (KR);	 β-hydroxy	 acyl	
ACP	dehydratase	(DH);	and	enoyl	ACP	reductase	(ER)	domains	
which	 process	 the	β-carbonyl	 formed	 by	 the	 KS.	 Finally,	 a	C-
methyl	transferase	(C-MeT)	domain	is	responsible	for	adding	a	
methyl	group	derived	from	S-adenosyl	methionine.	SQTKS	thus	
contains	a	full	set	of	active	HR-PKS	domains.	
	
Figure	 1.	 Structures	 of	 fungal	 highly	 reduced	 polyketides,	 and	 the	 structure	 of	
dimeric	 vFAS	 (PDB	 2VZ8)8	 which	 is	 homologous	 the	 squalestatin	 tetraketide	
synthase	(SQTKS).	See	text	for	abbreviations.	
	 SQTKS	shows	sequence	homology	to	vertebrate	FAS	(vFAS,	
Figure	1).8	This	similarity	even	extends	 to	 the	position	of	a	C-
MeT	domain	which	 is	 inactive	 in	 vFAS,	 but	which	 acts	 during	
the	 first	 and	 second	 rounds	 of	 chain	 processing	 by	 SQTKS.9	
vFAS	 produces	 fully	 saturated	 linear	 16-18	 carbon	 chains,	
whereas	SQTKS	produces	the	dimethylated	and	unsaturated	8-
carbon	chain	3.	SQTKS	thus	displays	a	complex	programme	in	
which	the	activities	of	 the	 individual	catalytic	domains	can	be	
varied	 (Scheme	 1).	 Our	 approach	 to	 study	 the	 programming	
mechanisms	 of	 fungal	 HR-PKS	 is	 to	 examine	 intrinsic	
selectivities	 of	 isolated	 catalytic	 domains.	 For	 example,	 we	
recently	 reported	on	the	chemo-	and	stereo-selectivity	of	 the	
isolated	SQTKS	ER	domain.10	Here	we	describe	work	to	extend	
this	study	to	the	isolated	DH	domain	of	SQTKS.	
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Scheme	1.	The	chemical	reactions	catalysed	by	SQTKS.	
	 SQTKS	 is	 a	 megacomplex	 of	 284.4	 KDa	 encoded	 by	 the	
phpks1	 gene.	 We	 have	 been	 unable	 to	 obtain	 it	 as	 a	 single	
soluble	 protein.	 However,	 by	 systematic	 variation	 of	 possible	
start	 and	 stop	 positions	 for	 PCR	 from	 an	 intron-free	 phpks1	
template,	we	were	able	to	create	an	open	reading	frame	which	
reliably	produces	soluble	SQTKS	DH	protein	when	expressed	in	
E.	coli	BL21	with	an	N-terminal	his6	tag.	The	DH	protein	of	the	
expected	 38.0	 kDa	 was	 purified	 to	 homogeneity	 by	 nickel	
affinity	 and	 gel-filtration	 chromatography.	 Calibrated	 gel	
filtration	 indicated	that	the	DH	exists	primarily	as	a	monomer	
(see	ESI).	The	isolated	DH	was	unstable	in	unmodified	buffers,	
precipitating	rapidly	even	at	low	temperatures.	However,	rapid	
removal	of	 imidazole	used	 for	 the	nickel	 ion	 chromatography	
and	 use	 of	 a	 buffer	 containing	 10%	 glycerol,	 50	mM	 Tris	 pH	
8.0,	150	mM	NaCl	and	100	mM	L-arginine	and	L-glutamic	acid	
dramatically	improved	protein	solubility	and	stability.		
	 N-acetyl	 cysteamine	 (NAC)	 is	 a	 truncated	 form	 of	 the	
phosphopantetheine	 (PP)	 cofactor	 which	 attaches	 acyl	 PKS	
intermediates	 to	 the	 ACP	 domain,	 and	 SNAC	 thiolesters	 are	
often	 used	 as	 PP	 surrogates	 for	 in	 vitro	 studies	 of	 PKS	
enzymes,11,12	 including	 DH	 domains.13,14	 We	 thus	 selected	
SNACs	as	targets	for	substrate	synthesis	(Scheme	2).	
	 The	 anti	 diketide	 SNAC	 2R,3R-8	 was	 made	 by	 a	 route	
involving	 Fráter-Seebach	 methylation15	 of	 commercially	
available	 enantiopure	 3-hydroxy	 butyrate	 4	 (Scheme	 2A)	 to	
give	5.	This	was	O-protected	with	TBDMS	to	give	6,	which	was	
in-turn	 hydrolysed	 to	 its	 corresponding	 acid	 and	 coupled	 to	
HSNAC	 to	 give	 the	 protected	 diketide	 7.	 Acidic	 deprotection	
then	yielded	2R,3R-8.		
	 The	 syn	 diketide	 SNAC	 2R,3S-13	 was	 made	 using	 Evans	
asymmetric	 aldol	 chemistry16	 to	 give	 the	 known	 syn	 aldol	
product	2R,3S,4'R-10	(Scheme	2B).	This	was	again	O-protected	
with	TBDMS	 to	give	11,	which	was	hydrolysed	and	processed	
to	 the	 protected	 SNAC	 2R,3S-12.	 Acidic	 deprotection	 then	
yielded	2R,3S-13.	
	 The	non-methylated	diketide	3R-16	was	made	from	4	by	a	
similar	 protection,	 thiolesterification	 and	 deprotection	 route	
(Scheme	2C).	The	enantiomers	of	all	the	diketides	were	made	
from	enantiomeric	starting	materials	using	identical	methods.	
	 DH	 activity	was	 assayed	using	 LCMS	 (See	 ESI)	 to	measure	
substrate	 consumption	 and	 product	 formation.	 Assays	 were	
set	up	to	 include	DH	protein,	substrate	and	buffer	at	30	˚C	 in	
100	µL	 assay	 volume,	 and	 20	µL	 aliquots	were	 taken	 at	 time	
points	 and	 quenched	 in	 CH3CN	 (60	 µL).	 Protein	 was	
precipitated	 by	 centrifugation	 and	 the	 supernatant	 was	
examined	directly	by	LCMS.	
	
Scheme	2.	Synthesis	of	potential	SNAC	substrates	for	the	SQTKS	DH	domain:	a,	
LDA	(2eq.),	-78	˚C,	then	MeI;	b,	TBDMSOTf,	pyridine,	0	˚C;	c,	aq.	LiOH,	60	˚C,	then	
HSNAC,	 EDCI,	 DMAP,	 0	 ˚C;	 d,	 THF/H2O/HOAc,	 RT,	 5	 days;	 e,	 Bu2BOTf,	 CH2Cl2,	
Et3N,	 -78	 ˚C,	 then	CH3CHO;	 f,	TBDMSCl,	CH2Cl2,	DMAP,	 imidazole,	RT;	g,	 LiOOH,	
H2O,	RT,	then	HSNAC,	EDCI,	DMAP,	0	˚C.	TBDMS	=	(Si(Me2)CMe3).	
	 In	order	to	maximise	sensitivity,	single	ion	monitoring	was	
applied	for	substrate	and	product	peaks	and	peak	areas	were	
integrated.	 The	 peak	 integrals	 were	 calibrated	 vs	 known	
concentrations	 of	 substrate	 and	 product.	 Initial	 rates	 were	
determined	by	plotting	product	concentration	vs	 assay	 times,	
and	 variation	 of	 initial	 substrate	 concentrations	 allowed	 the	
estimation	 of	 kinetic	 parameters	 (Figure	 2).	 The	 diketide	
2R,3R-8	was	 dehydrated	 by	 the	DH	 to	 give	 exclusively	 the	E-
olefin	product	tigloyl	SNAC	17,	but	none	of	the	other	2-methyl	
diketides	 showed	 any	 turn-over.	 Of	 the	 non-methylated	
diketides,	 only	 3R-16	was	 a	 substrate,	 although	much	 slower	
than	2R,3R-8.	The	ability	of	the	non-substrates	2S,3S-8	and	the	
enantiomers	 of	 13	 to	 act	 as	 inhibitors	 of	 the	 DH	 was	
investigated.	 However,	 addition	 of	 each	 of	 these	 compounds	
to	 assays	 containing	 the	 substrate	 2R,3R-8	 showed	 no	
appreciable	 decrease	 in	 rate	 when	 added	 in	 mM	
concentrations	(see	ESI).	
	 Despite	having	access	to	soluble	protein	we	were	unable	to	
grow	satisfactory	crystals	of	the	isolated	DH	domain.	In	lieu	of	
other	 structural	 information	 we	 built	 a	 model	 of	 SQTKS	 DH	
based	 on	 the	 known	 crystal	 structures	 of	 DH	 proteins	 from	
other	 Type	 I	 systems	 reported	 in	 the	 literature.	 These	 form	
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distinctive	double	hot-dog	folds.17	In	particular	the	DH	domain	
from	 CurF,18	 a	 modular	 type	 I	 PKS,	 formed	 an	 appropriate	
template	 for	 the	 assembly	 of	 a	 model	 by	 the	 SwissModel	
threading	server.19	Comparison	of	the	results	showed	that	the	
backbone	atoms	of	the	SQTKS	DH	model	and	CurF-DH	had	only	
1.4	 Å	 root	 mean	 square	 deviation	 (RMSD).	 Almost	 all	 of	 the	
observed	deviation	was	concentrated	on	the	periphery	of	the	
model	structure,	and	examination	of	the	conserved	active	site	
aspartic	 acid	 (D1225)	 and	 histidine	 (H1034)	 residues	 showed	
that	these	amino	acids	are	located	in	the	same	positions	in	the	
CurF	 DH	 and	 the	 model	 (see	 ESI).	 In	 addition	 a	 highly	
conserved	Y/FP	motif	(Y/F1041-P1042)	is	also	preserved	in	the	
model.	
	
Figure	 2.	 Kinetic	 data	 for	 SQTKS	 DH	 reactions.	 A,	 raw	 time	 course	 data	 showing	
increase	in	tigloyl	SNAC	17	concentration;	B,	comparison	of	DH	reaction	rate	for	the	4	
diketide	stereoisomers.	
	 The	 diketide	 substrate	 2R,3R-8	was	 then	 docked	 into	 the	
DH	 active	 site	 using	 a	 combination	 of	 manual	 positioning	
(PyMol)20	and	optimisation	and	energy	minimisation	using	the	
YASARA	 force	 field.21	 For	 2R,3R-8,	 the	 docked	 model	 shows	
that	the	thiolester	carbonyl	oxygen	is	within	hydrogen	bonding	
distance	of	the	backbone	NH	of	G1043	(2.9	Å),	and	aligns	with	
the	dipole	of	 the	helix	between	G1043	and	M1055	of	 the	DH	
model.	 The	 SNAC	 NH	 is	 positioned	 within	 hydrogen	 bonding	
distance	of	the	backbone	carbonyl	of	conserved	Y1041	(2.0	Å);	
while	the	SNAC	carbonyl	is	2.8	Å	from	backbone	NH	of	M1083.	
These	 interactions	 locate	 the	 SNAC	 in	 the	 entrance	 to	 the	
reaction	 cavity	 and	would	 presumably	 perform	 a	 similar	 role	
with	 the	 pantetheinyl-ACP-bound	 substrate	 in	 the	 native	
complex.	 The	 two	 methyl	 groups	 of	 2R,3R-8	 occupy	 open	
space	and	allow	the	α-proton	and	β-hydroxyl	to	approach	the	
conserved	 histidine	 and	 aspartate	 residues.	 The	 closest	
distance	 between	 the	 α-proton	 and	 the	 nearest	 nitrogen	 of	
H1034	is	3.6	Å,	while	the	distance	between	the	β-hydroxyl	and	
the	oxygen	of	D1225	is	3.0	Å.	The	geometry	of	the	interactions	
is	 consistent	 with	 a	 syn	 abstraction	 of	 water	 to	 give	 the	
observed	 E-2-methylbut-2-enoyl	 (tigloyl)	 SNAC	 product	 17.	
Attempts	 to	dock	 the	other	stereoisomers	of	 the	diketide	did	
not	give	satisfactory	results.	
	
Figure	3.	Key	modelled	interactions	between	the	substrate	2R,3R-7b	(cyan)	and	
the	DH	(green).	
	 Our	 experiments	 report	 the	 first	 in	 vitro	 studies	 of	 the	
stereoselectivity	 of	 an	 isolated	 DH	 domain	 from	 an	 iterative	
Type	I	PKS.	Using	a	kinetic	assay	we	measured	the	KM	(4.5	mM)	
and	 kcat	 values	 (0.063⋅min
-1).	 While	 these	 values	 have	 little	
absolute	meaning,	they	are	comparable	with	values	measured	
for	 other	 DH	 proteins.	 For	 example	 Aldrich,	 Smith	 and	
coworkers	 reported	KM	 values	 in	 the	same	range	 for	a	KR-DH	
didomain	 from	 module	 2	 of	 the	 pikromycin	 modular	 PKS	
(pikKR2-DH2)	 acting	 on	 triketide	 mimics,	 although	 their	 kcat	
values	are	ten-fold	higher.13	
	 Only	one	2-methylated	diketide,	2R,3R-8,	 is	 accepted	as	a	
substrate	for	SQTKS	DH,	with	no	dehydation	activity	observed	
for	 its	 enantiomer	2S,3S-8	or	either	of	 the	 syn	 diastereomers	
13.	 Since	 these	 stereoisomers	 show	no	measurable	 substrate	
or	 inhibition	activity	 it	seems	unlikely	that	they	can	be	bound	
at	the	DH	active	site,	also	supported	by	the	failure	to	generate	
satisfactory	 docked	 models	 of	 these	 isomers.	 However	 the	
non-methylated	diketide	3R-16	is	a	substrate.	
	 In	 the	 active	 SQTKS	 the	 ACP-bound	 2R,3R-diketide	 20	 is	
created	by	reduction	of	a	3-oxo	diketide	19	by	the	KR	domain	
using	NADPH	as	the	cofactor	 (Scheme	3).	Our	results	strongly	
suggest	 that	the	SQTKS	KR	releases	3R	 substrates,	and	thus	 it	
must	 reduce	 the	 3-oxo	 group	 of	 its	 substrate	 19	 by	 3-Si	
addition	of	hydride.	Since	racemisation	at	the	2-position	of	the	
diketide	 is	 strongly	 disfavoured	 after	 reduction	 of	 the	 3-oxo	
group,	 this	observation	also	suggests	 that	 the	KR	accepts	and	
releases	 2R-methylated	 diketides	 (e.g.	 2R-19,	 Scheme	 3).	
However,	 because	 facile	 epimerisation	 of	 2-methyl-3-oxo	
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substrates	such	as	19	is	likely,	it	is	not	yet	possible	to	infer	the	
stereochemical	 preference	 of	 the	 C-MeT	 without	 further	
experiments.	Our	previous	results	have	shown	that	the	SQTKS	
ER	 domain	 can	 process	 both	 Z	 22	 and	 E	 23	 substrates.	
However	since	the	DH	can	only	provide	E-diketides	 it	appears	
that	the	ER's	ability	to	accept	Z-olefins	is	merely	adventitious.10	
	 In	 our	 earlier	 study	 of	 the	 stereoselectivity	 of	 the	 ER	
domain	we	showed	that	the	stereochemical	preferences	at	the	
β-carbon	are	 identical	 for	SQTKS	ER	and	vFAS	ER,	 in	 terms	of	
both	the	cofactor	itself	(transfer	of	4'-pro-R	Hydrogen)	and	the	
substrate	 (addition	 of	 hydride	 to	 to	 the	 3-Re	 face).10	 The	
results	of	 this	study	also	show	that	 the	SQTKS	DH	has	exactly	
the	 same	 stereochemical	 selectivity	 as	 the	 vFAS	 DH	 which	
dehydrates	 2R,3R	 substrates	20	 to	 give	E-products	23	 by	 syn	
elimination.22	Even	though	the	SQTKS	substrate	 is	methylated	
at	 the	2-position,	 the	2R	 stereochemistry	 ensures	 that	 the	2-
pro-S	proton	is	removed	during	reaction.	Our	model	structure	
shows	 that	 the	 2R,3R	 substrate	 aligns	 with	 the	 active	 site	
residues	 such	 that	 syn	 elimination	 gives	 the	 observed	 E-
product.	 The	 active	 site	 residues	 involved,	 H1034,	 D1225,	
Y1041	and	P1042	are	conserved	between	the	SQTKS	and	vFAS	
sequences.	
	
Scheme	3.	Stereochemical	course	of	KR,	DH	and	ER	domains	of	SQTKS.	
	 Finally,	the	SQTKS	KR	domain	also		operates	with	the	same	
stereochemical	preference	as	the	vFAS	KR.22	Although	we	have	
not	yet	been	able	to	show	which	of	the	cofactor	4'-hydrides	is	
transferred	by	KR,	the	reduction	does	occur	at	the	3-Si	face	of	
the	substrate.	Thus	our	studies	show	that	SQTKS	shares	more	
than	 just	 sequence	 homology	 and	 domain	 organisation	 with	
vFAS:	 its	 fundamental	mechanisms	 for	 substate	 reaction	 and	
stereoselectivity	are	also	preserved	and	reinforce	the	idea	that	
fungal	hr-PKS	and	vFAS	evolved	from	a	common	ancestor.	Our	
current	 work	 focusses	 on	 determining	 the	 stereochemical	
preference	of	 the	CMeT	domain	and	attempts	at	engineering	
SQTKS	to	rationaly	change	its	selectivity.	
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